AIDX
20/20 BiolabsยทNASDAQ
--
--(--)
--
--(--)
Is AIDX undervalued or overvalued?
- AIDX scores 0.00/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, -180.14% net margin, -35.27 P/E ratio, 1196.78 P/B ratio, and 0.00% earnings growth, these metrics solidify its Neutral investment rating.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
